Showing results (71-80 of 266) with videos related to

Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry|January 11, 2026
Structure-activity relationship study of a new class of 2-amino-3,4-dihydroquinazolines as antitubercular agentsLena Trifonov, Helena I Boshoff, Jose Santinni O Roma, et al.
The Journal of Biological Chemistry|July 13, 2004
The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of actionHelena I M Boshoff, Timothy G Myers, Brent R Copp, et al.
Medchemcomm|March 25, 2017
SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc1 inhibitorsNarisa Phummarin, Helena I Boshoff, Patricia S Tsang, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|January 2, 2007
Systems biology and its impact on anti-infective drug developmentMichael P Stumpf, Brian D Robertson, Ken Duncan, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Synthesis and Structure-Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular AgentsVeena D Yadav, Helena I Boshoff, Lena Trifonov, et al.
Nature|September 3, 2004
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune responseMichael B Reed, Pilar Domenech, Claudia Manca, et al.
Science (New York, N.Y.)|August 13, 2011
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosisWanliang Shi, Xuelian Zhang, Xin Jiang, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivoKathleen England, Helena I M Boshoff, Kriti Arora, et al.
Pageof 27